Recordati Rare Diseases North America
Paolo Severino is a National Medical Science Liaison at Recordati Rare Diseases Inc. since July 2022, bringing extensive experience from previous roles at Jazz Pharmaceuticals as a Medical Science Liaison for Central and Southern Italy and Key Account Manager from April 2014 to July 2022. Prior to that, Paolo worked at Shire Human Genetic Therapies as a Senior Product Specialist from June 2006 to March 2014. Academic qualifications include a Laurea Magistrale Vecchio Ordinamento in Scienze Biologiche from Università degli Studi di Napoli Federico II, achieved between 1999 and 2006, and a Diploma di Maturità from a scientific high school completed in 1999.
This person is not in any offices
Recordati Rare Diseases North America
1 followers
Recordati Rare Diseases Inc. (RRD) markets products to treat rare diseases. RRD is a member of the Recordati Group, which includes Recordati S.p.A., Orphan Europe, among other companies around the globe. The Recordati Group, which was established in 1926 currently employs more than 4,000 worldwide. The RRD mission is to reduce the impact of extremely rare and devastating diseases by providing urgently needed therapies. We work side-by-side with rare disease communities to increase awareness, improve diagnosis and expand availability of treatments for people with rare diseases.